Cargando…
Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens
Cancer somatic mutations can generate neoantigens that distinguish malignant from normal cells (1–7). However, the personalized identification and validation of neoantigens remains a major challenge. Here we discover neoantigens in human mantle cell lymphomas using an integrated genomic and proteomi...
Autores principales: | Khodadoust, M.S., Olsson, N., Wagar, L.E., Haabeth, O.A.W., Chen, B., Swaminathan, K., Rawson, K., Liu, C.L., Steiner, D., Lund, P., Rao, S., Zhang, L., Marceau, C., Stehr, H., Newman, A.M., Czerwinski, D. K., Carlton, V.E.H., Moorhead, M., Faham, M., Kohrt, H.E., Carette, J., Green, M.R., Davis, M.M., Levy, R., Elias, J. E., Alizadeh, A.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808925/ https://www.ncbi.nlm.nih.gov/pubmed/28329770 http://dx.doi.org/10.1038/nature21433 |
Ejemplares similares
-
Acute myeloid leukemia immunopeptidome reveals HLA presentation of mutated nucleophosmin
por: Narayan, Rupa, et al.
Publicado: (2019) -
Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation
por: Li, Lijin, et al.
Publicado: (2021) -
Autologous tumor cell vaccine induces antitumor T cell immune responses in patients with mantle cell lymphoma: A phase I/II trial
por: Frank, Matthew J., et al.
Publicado: (2020) -
Neoantigen Targetability in Progressive Advanced Melanoma
por: van den Bulk, Jitske, et al.
Publicado: (2023) -
Lymphoma neoantigens
por: Elias, Joshua E.
Publicado: (2018)